Researchers describe pegcetacoplan, a new class of medication, as the “closest thing to a cure” for the rare, severe kidney disease C3 glomerulopathy.

Omeros Corporation (Nasdaq: OMER) today announced the closing of the asset sale and licensing transaction between Omeros and Novo Nordisk for the candidate drug zaltenibart (formerly OMS906).

Omeros stock rises after a $340 million deal with Novo Nordisk. Learn about its improved risk profile and covered call trade ...

ATLANTA — Residents in a Buckhead senior community said they've endured two sleepless nights due to loud classical music and flashing blue lights coming from a mobile surveillance system installed in ...

LAS VEGAS (FOX5) — Camera systems mounted on trailers with flashing blue lights and solar panels have become a common sight along Las Vegas Valley streets, but many aren’t operated by law enforcement.

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

Lots of people are excited about the idea of using plants to help us draw down some of the excess carbon dioxide we’ve been pumping into the atmosphere. It would be nice to think that we could ...

Among people with sickle cell disease—an inherited blood disorder—acute chest syndrome (ACS) is the leading cause of death. The condition is the result of red blood cells becoming stiff, sticky, and ...

ARO-C3 treatment led to deep and sustained reductions in alternative pathway complement activity and proteinuria. ARO-C3, an investigational RNA interference-based therapy targeting hepatic expression ...

The complement system is an essential part of innate immunity, consisting of more than 30 proteins. A critical element in the pathway is C1q (Complement 1 q), an important recognition molecule in the ...

In partnership with The Repository, every Monday, Stark Community Foundation highlights positive happenings in our community. Here’s to Good News Mondays! Children who have experienced neglect, abuse ...